Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 32

The DOI matches its Crossref record.

Topical Minocycline Effectively Decontaminates and Reduces Inflammation in Infected Porcine Wounds

Daly, Lauren Tracy, Tsai, David M., Singh, Mansher, Nuutila, Kristo, Minasian, Raquel A., Lee, Cameron C. Y., Kiwanuka, Elizabeth, Hackl, Florian, Onderdonk, Andrew B., Junker, Johan P. E., Eriksson, Elof, Caterson, Edward J.·2016·Plastic & Reconstructive Surgery

Abstract

Background: Wound infection can impair postoperative healing. Topical antibiotics have potential to treat wound infection and inflammation and minimize the adverse effects associated with systemic antibiotics. Methods: Full-thickness porcine wounds were infected with Staphylococcus aureus. Using polyurethane wound enclosure devices, wounds were treated with topical 100 μg/ml minocycline, topical 1000 μg/ml minocycline, topical saline control, or 4 mg/kg intravenous minocycline. Bacteria were quantified in wound tissue and fluid obtained over 9 hours. Immunosorbent assays were used to analyze inflammatory marker concentrations. Minocycline’s effect on in vitro migration and proliferation of human keratinocytes and fibroblasts was tested using scratch assays and metabolic assays, respectively. Results: After 6 hours, 100 and 1000 μg/ml topical minocycline decreased bacteria in wound tissue to 3.5 ± 0.87 and 2.9 ± 2.3 log colony-forming units/g respectively, compared to 8.3 ± 0.9 log colony-forming units/g in control wounds (p < 0.001) and 6.9 ± 0.2 log colony-forming units/g in wounds treated with 4 mg/kg intravenous minocycline (p < 0.01). After 2 hours, topical minocycline reduced concentrations of the inflammatory cytokines interleukin-1β, interleukin-6, and tumor necrosis factor-α (p < 0.01), and inflammatory cell counts in wound tissue (p < 0.05). In noninfected wounds, topical minocycline significantly reduced interleukin-1β, interleukin-6, and inflammatory cell counts after 4 hours (p < 0.01). Matrix metalloproteinase-9 concentrations decreased after 1-hour treatment (p < 0.05). Keratinocyte and fibroblast in vitro functions were not adversely affected by 10 μg/ml minocycline or less. Conclusions: Topical minocycline significantly reduces bacterial burden and inflammation in infected wounds compared with wounds treated with intravenous minocycline or control wounds. Minocycline also decreases local inflammation independently of its antimicrobial effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/prs.0000000000002633

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Pittet, 2008, Infection control as a major World Health Organization priority for developing countries., J Hosp Infect, 68, 285, 10.1016/j.jhin.2007.12.013 · DOI · Paper page
  2. Cruse, 1980, The epidemiology of wound infection: A 10-year prospective study of 62,939 wounds., Surg Clin North Am, 60, 27, 10.1016/S0039-6109(16)42031-1 · DOI · Paper page
  3. Twum-Danso, 1992, Microbiology of postoperative wound infection: A prospective study of 1770 wounds., J Hosp Infect, 21, 29, 10.1016/0195-6701(92)90151-B · DOI
  4. Bayat, 2003, Skin scarring., BMJ, 326, 88, 10.1136/bmj.326.7380.88 · DOI · Paper page
  5. Gurtner, 2008, Wound repair and regeneration., Nature, 453, 314, 10.1038/nature07039 · DOI · Paper page
  6. van der Veer, 2009, Potential cellular and molecular causes of hypertrophic scar formation., Burns, 35, 15, 10.1016/j.burns.2008.06.020 · DOI · Paper page
  7. Ray, 2013, The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar., J Invest Dermatol, 133, 1212, 10.1038/jid.2012.499 · DOI
  8. Gallant-Behm, 2005, Cytokine and growth factor mRNA expression patterns associated with the hypercontracted, hyperpigmented healing phenotype of red duroc pigs: A model of abnormal human scar development?, J Cutan Med Surg, 9, 165, 10.1007/s10227-005-0105-4 · DOI
  9. Bendy, 1964, Relationship of quantitative intravenous wound bacterial counts to healing of decubiti: Effect of topical gentamicin., Antimicrob Agents Chemother (Bethesda), 10, 147
  10. Robson, 1968, Quantitative bacteriology and delayed wound closure., Surg Forum, 19, 501
  11. Robson, 1969, Bacterial quantification of open wounds., Mil Med, 134, 19, 10.1093/milmed/134.1.19 · DOI · Paper page
  12. Böcker, 1991, Evaluation of the hepatotoxic potential of minocycline., Antimicrob Agents Chemother, 35, 1434, 10.1128/AAC.35.7.1434 · doi:10.1128/aac.35.7.1434
  13. Garrido-Mesa, 2013, What is behind the non-antibiotic properties of minocycline?, Pharmacol Res, 67, 18, 10.1016/j.phrs.2012.10.006 · DOI · Paper page
  14. Giuliani, 2005, Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction., J Leukoc Biol, 78, 135, 10.1189/jlb.0804477 · DOI
  15. Leite, 2011, Anti-inflammatory properties of doxycycline and minocycline in experimental models: An in vivo and in vitro comparative study., Inflammopharmacology, 19, 99, 10.1007/s10787-011-0077-5 · DOI
  16. Kloppenburg, 1996, The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes., Antimicrob Agents Chemother, 40, 934, 10.1128/AAC.40.4.934 · DOI
  17. Wang, 2004, Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria., J Biol Chem, 279, 19948, 10.1074/jbc.M313629200 · DOI · Paper page
  18. Castanares, 2005, Minocycline up-regulates BCL-2 levels in mitochondria and attenuates male germ cell apoptosis., Biochem Biophys Res Commun, 337, 663, 10.1016/j.bbrc.2005.09.101 · DOI
  19. Wang, 2003, Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington’s disease., Proc Natl Acad Sci USA, 100, 10483, 10.1073/pnas.1832501100 · DOI · Paper page
  20. Choi, 2007, Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer’s disease models., Neuropsychopharmacology, 32, 2393, 10.1038/sj.npp.1301377 · DOI · Paper page
  21. Dumont, 2010, Minocycline inhibits apoptotic cell death in a murine model of partial flap loss., J Reconstr Microsurg, 26, 523, 10.1055/s-0030-1262952 · doi:10.1055/s-0030-1262952
  22. Kiwanuka, 2011, Comparison of healing parameters in porcine full-thickness wounds transplanted with skin micrografts, split-thickness skin grafts, and cultured keratinocytes., J Am Coll Surg, 213, 728, 10.1016/j.jamcollsurg.2011.08.020 · DOI
  23. Hall, 1977, Rapid fluorimetric assay of minocycline in plasma or serum: Comparison with microbiological assay., Br J Clin Pharmacol, 4, 57, 10.1111/j.1365-2125.1977.tb00667.x · doi:10.1111/j.1365-2125.1977.tb00667.x
  24. Liang, 2007, In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro., Nat Protoc, 2, 329, 10.1038/nprot.2007.30 · DOI · Paper page
  25. Cory, 1991, Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture., Cancer Commun, 3, 207, 10.3727/095535491820873191 · DOI · Paper page
  26. Henry, 2007, The inhibitory effect of minocycline on hypertrophic scarring., Plast Reconstr Surg, 120, 80, 10.1097/01.prs.0000263325.73400.f8 · DOI
  27. Fagan, 2010, Minocycline to improve neurologic outcome in stroke (MINOS): A dose-finding study., Stroke, 41, 2283, 10.1161/STROKEAHA.110.582601 · DOI · Paper page
  28. Agwuh, 2006, Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines., J Antimicrob Chemother, 58, 256, 10.1093/jac/dkl224 · DOI · Paper page
  29. Salgado, 2012, Post-burn hypertrophic scars are characterized by high levels of IL-1β mRNA and protein and TNF-α type I receptors., Burns, 38, 668, 10.1016/j.burns.2011.12.012 · DOI
  30. Messadi, 2004, Activation of NFkappaB signal pathways in keloid fibroblasts., Arch Dermatol Res, 296, 125, 10.1007/s00403-004-0487-y · DOI
  31. Ghazizadeh, 2007, Essential role of IL-6 signaling pathway in keloid pathogenesis., J Nippon Med Sch, 74, 11, 10.1272/jnms.74.11 · DOI
  32. Ladak, 2009, Pathophysiology and management of the burn scar., Clin Plast Surg, 36, 661, 10.1016/j.cps.2009.05.014 · DOI
  33. Kobayashi, 2014, Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels., Am J Physiol Lung Cell Mol Physiol, 306, L1006, 10.1152/ajplung.00015.2014 · DOI · Paper page
  34. Stevens, 2012, A secreted MMP is required for reepithelialization during wound healing., Mol Biol Cell, 23, 1068, 10.1091/mbc.e11-09-0745 · DOI
  35. Simonetti, 2012, Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation., J Antimicrob Chemother, 67, 191, 10.1093/jac/dkr440 · DOI
  36. Vanheusden, 1998, In vitro modulation of human gingival epithelial cell attachment and migration by minocycline-HCL., J Periodontal Res, 33, 377, 10.1111/j.1600-0765.1998.tb02213.x · doi:10.1111/j.1600-0765.1998.tb02213.x
  37. Ghica, 2013, Response surface methodology and Taguchi approach to assess the combined effect of formulation factors on minocycline delivery from collagen sponges., Pharmazie, 68, 340
  38. Uehara, 2016, Comparison of the anti-angiogenic and anti-inflammatory effects of two antibiotics: Clarithromycin versus moxifloxacin., Curr Eye Res, 41, 474

Cited by

See all 32

Metadata

Authors
Daly, L. T., Tsai, D. M., Singh, M., Nuutila, K., Minasian, R. A., Lee, C. C. Y., Kiwanuka, E., Hackl, F., Onderdonk, A. B., Junker, J. P. E., Eriksson, E., & Caterson, E. J.
Venue
Plastic & Reconstructive Surgery
Published
2016-11
Volume
138
Issue
5
Pages
856e-868e
ISSN
0032-1052
Cited by
32
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Topical Minocycline Effectively Decontaminates and Reduces Inflammation in Infected Porcine Wounds. https://app.cochat.ai/papers/10.1097/prs.0000000000002633
The paper
Daly, L. T., Tsai, D. M., Singh, M., Nuutila, K., Minasian, R. A., Lee, C. C. Y., Kiwanuka, E., Hackl, F., Onderdonk, A. B., Junker, J. P. E., Eriksson, E., & Caterson, E. J. (2016). Topical Minocycline Effectively Decontaminates and Reduces Inflammation in Infected Porcine Wounds. Plastic & Reconstructive Surgery. https://doi.org/10.1097/prs.0000000000002633

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.